{
  "ptid_time": "036_S_5063_2013-04-19",
  "img_path": "/data/qiuhui/data/adni/images/036_S_5063/2013-04-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,915 mm³, 31.5% above the reference mean. With a Z-score of 0.72 (76.5th percentile), this represents normal volume ; hippocampal volume measures 5,364 mm³, 24.6% below the reference mean. With a Z-score of -2.26 (1.2th percentile), this represents significant atrophy; whole brain volume measures 817,421 mm³, 16.1% below the reference mean. With a Z-score of -2.03 (2.1th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,473 mm³, 32.7% below the reference mean. With a Z-score of -2.01 (2.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,307 mm³, 21.8% below the reference mean. With a Z-score of -1.98 (2.4th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 12,542 mm³, 34.6% below the reference mean. With a Z-score of -3.00 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 71.5 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Endocrine-Metabolic; Hematopoietic-Lymphatic; Renal-Genitourinary; Smoking; Major Surgical Procedures. MMSE: 25.0. MoCA: 16.0. Logical Memory: 0.0. Laboratory findings: Cholesterol (High Performance): 269.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.62 SUVR (profound elevated); Amyloid beta: 551.80 pg/mL (mild reduced); Total tau: 445.40 pg/mL (significant elevated); Phosphorylated tau: 40.94 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, middle temporal gyrus) alongside elevated biomarkers (Aβ, tau, AV45). Cognitive scores (MoCA 16, MMSE 25) suggest impairment, though MMSE is borderline. APOE4 positivity further supports Alzheimer's pathology.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Note: The profound middle temporal gyrus atrophy and biomarker profile strongly align with AD, but vascular or mixed pathology should be ruled out clinically.)*",
  "timestamp": "2025-07-26T06:20:22.949234"
}